Steven Cohen's Point72 Asset Management Acquires New Stake in Sagimet Biosciences Inc

On February 2, 2024, Point72 Asset Management, led by renowned investor Steven Cohen (Trades, Portfolio), executed a significant buy action, acquiring 1,612,639 shares in Sagimet Biosciences Inc (NASDAQ:SGMT). The addition of these shares to Point72's portfolio represents a 0.05% impact, with the firm now holding a 5.30% stake in Sagimet Biosciences Inc.

Related Keywords

,Financial Health Of Sagimet Biosciences Inc ,Sagimet Biosciences Inc ,Biosciences Inc ,Steven Cohen ,Sagimet Biosciences ,Financial Strength ,Balance Sheet Rank ,Profitability Rank ,Growth Rank ,Momentum Rank ,Point72 Asset Management ,Portfolio ,Grades ,Meta Platforms Inc ,Iopharmaceutical Company ,